Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhizhu Kuanzhong is a standardized traditional Chinese medicine (TCM) herbal formula, primarily used for the treatment of functional dyspepsia and related gastrointestinal disorders. The formulation is derived from classical TCM prescriptions—Zhizhu decoction and Zhizhu pill—and contains four botanical ingredients: Rhizoma Atractylodis Macrocephalae (Atractylodes macrocephala), Fructus Aurantii Immaturus (Citrus × aurantium L.), Radix Bupleuri Chinensis (Bupleurum chinense), and Fructus Crataegi Pinnatifidae (Crataegus pinnatifida). The product is manufactured as concentrated granules packed into capsules. Mechanistically, it acts on multiple targets associated with gastrointestinal motility and sensation, including modulation of 5-hydroxytryptamine (serotonin) pathways and greater splanchnic afferent activity. Clinical studies have shown efficacy in alleviating symptoms of functional dyspepsia, especially postprandial distress syndrome subtype, improving gastric hypersensitivity and motor dysfunction[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhizhu Kuanzhong.